CLDN11 and nasopharyngeal carcinoma: This treatment effectively blocked the migration ability of TW02 and HK1 cells in a dose-dependent manner (Fig. 5f) without affecting cell viability (Fig. 5g), thus indicating that the nocodazole treatment results were similar to those of CLDN11 re-expression in NPC cells.